InSite Vision Updates Special Protocol Assessment Submission To FDA For Phase 3 Trial Of AzaSite Plus™ And DexaSite™
InSite Vision Incorporated (OTCBB:INSV) today announced that the Company recently received eight minor recommendations regarding its proposed agreement with the U.S...